Azenta Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Azenta Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- AZTA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000933974
Board of directors
-
Alan J. Malus · DirectorSince 2024
-
Didier Hirsch · DirectorSince 2024
-
Dipal Doshi · DirectorSince 2025
-
Dorothy E. Puhy · DirectorSince 2023
-
Edward Peter Bousa · DirectorSince 2024
- Since 2023
-
Erica McLaughlin · DirectorSince 2023
-
Frank Casal · DirectorSince 2023
-
John Marotta · Director · President and CEOSince 2024
-
Joseph R. Martin · DirectorSince 2023
-
Krishna G. Palepu · DirectorSince 2023
- Since 2024
-
Michael Rosenblatt · DirectorSince 2023
-
Quentin Koffey · DirectorSince 2024
-
Robyn C. Davis · DirectorSince 2023
-
Stephen S. Schwartz · Director · CEOSince 2023
-
Tina Susan Nova · DirectorSince 2023
-
William L. Cornog · DirectorSince 2024
Chief executives
John Marotta
· President and CEO
Dates unknown
Stephen S. Schwartz
· CEO
Dates unknown
Board connections
11 of this board's directors also sit on 21 other boards.
- via Joseph R. Martin and Krishna G. Palepu
- via Ellen M. Zane and Martin D. Madaus
- via Tina Susan Nova
- via Ellen M. Zane
- via William L. Cornog
- via Edward Peter Bousa
- via Dipal Doshi
- via Tina Susan Nova
- via Ellen M. Zane
- via Edward Peter Bousa
- via Didier Hirsch
- via William L. Cornog
- via Dorothy E. Puhy
- via Edward Peter Bousa
- via Stephen S. Schwartz
- via Martin D. Madaus
- via Martin D. Madaus
- via Didier Hirsch
- via Stephen S. Schwartz
- via Martin D. Madaus
- via Ellen M. Zane
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $171,896
- 2 purchases by 2 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 22, 2026 | Martin D. Madaus Officer (Interim CEO) | Shares withheld for tax | −1,456 | $34.28 | $49,912 |
| Sep 15, 2026 | Bello Erik J. Officer (VP Chief Accounting Officer) | Grant or award | +4,586 | — | — |
| Sep 14, 2026 | Starr Ephraim Officer (SVP, Gen Counsel & Secretary) | Grant or award | +15,272 | — | — |
| Sep 14, 2026 | Lin Lawrence Y. Officer (EVP, CFO and Treasurer) | Grant or award | +30,544 | — | — |
| Sep 14, 2026 | Pirogova Olga Officer (SVP and CHRO) | Grant or award | +15,272 | — | — |
| Sep 14, 2026 | MARTIN WILLIAM E. III Officer (President Multiomics) | Grant or award | +15,272 | — | — |
| Sep 14, 2026 | Martin D. Madaus Officer (Interim CEO) | Grant or award | +36,653 | — | — |
| Aug 9, 2026 | Pirogova Olga Officer (SVP and CHRO) | Shares withheld for tax | −1,085 | $32.04 | $34,763 |
| Jul 31, 2026 | Starr Ephraim Officer (SVP, Gen Counsel & Secretary) | Open-market purchase | +335 | $24.17 | $8,096 |
| May 18, 2026 | William L. Cornog Director | Open-market purchase | +10,000 | $16.38 | $163,800 |
| May 15, 2026 | Starr Ephraim Officer (SVP, Gen Counsel & Secretary) | Shares withheld for tax | −3,621 | $16.02 | $58,008 |
| Apr 28, 2026 | MARTIN WILLIAM E. III Officer (President Multiomics) | Grant or award | +17,790 | $24.24 | $431,230 |
| Feb 6, 2026 | Tina Susan Nova Director | Grant or award | +5,663 | $27.85 | $157,715 |
| Feb 5, 2026 | Dipal Doshi Director | Grant or award | +5,663 | $27.85 | $157,715 |
| Feb 5, 2026 | Frank Casal Director | Grant or award | +7,243 | $27.85 | $201,718 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.